Salgado H C, Krieger E M
Department of Physiology, School of Medicine of Ribejrão Preto, University of São Paulo, Brazil.
Hypertension. 1988 Feb;11(2 Pt 2):I121-5. doi: 10.1161/01.hyp.11.2_pt_2.i121.
We investigated the effect of sodium nitroprusside, verapamil, and hemorrhage on the resetting of the aortic baroreceptors of normotensive control rats to hypotension, and the reversal of resetting of baroreceptors of one-kidney, one clip hypertensive rats to normotension. Using whole-nerve recording, the extent (%) of resetting (or reversal of resetting) observed 15 minutes after a maintained fall in mean arterial pressure (MAP) was evaluated by the ratio between changes of systolic threshold pressure for baroreceptor activation and changes of control diastolic pressure exhibited by the rats, multiplied by 100. Three groups of normotensive control rats showed a MAP decrease to hypotensive levels of 33%, 39%, and 41%, respectively, with sodium nitroprusside, verapamil, and hemorrhage. The corresponding extent of resetting was 96 +/- 3%, 39 +/- 2%, and 46 +/- 4%, respectively. Only in the group treated with verapamil did MAP and systolic threshold pressure not revert completely to normotensive levels 15 minutes after the end of drug infusion. Three groups of one-kidney, one clip hypertensive rats showed MAP normalization of 30%, 37%, and 31%, respectively, with sodium nitroprusside, verapamil, and hemorrhage. The corresponding extent of reversal of resetting to normotension was 107 +/- 3%, 40 +/- 2%, and 60 +/- 9%, respectively. Again, only in the group treated with verapamil did MAP and systolic threshold pressure not revert to hypertensive levels 15 minutes after infusion. Besides indicating that different vasodilators can differently modulate the rapid (15-minute) resetting (or reversal of the resetting) due to similarly maintained fall in MAP, these data suggest that verapamil has a nonspecific effect on the baroreceptors, whereas sodium nitroprusside appears to affect baroreceptor transduction.
我们研究了硝普钠、维拉帕米和出血对正常血压对照大鼠主动脉压力感受器向低血压状态重调定的影响,以及对单肾单夹高血压大鼠压力感受器向正常血压状态重调定逆转的影响。采用全神经记录法,在平均动脉压(MAP)持续下降15分钟后,通过压力感受器激活的收缩阈压力变化与大鼠对照舒张压变化之比乘以100来评估重调定(或重调定逆转)的程度(%)。三组正常血压对照大鼠分别经硝普钠、维拉帕米和出血处理后,MAP下降至低血压水平,降幅分别为33%、39%和41%。相应的重调定程度分别为96±3%、39±2%和46±4%。仅用维拉帕米处理的组在药物输注结束15分钟后,MAP和收缩阈压力未完全恢复到正常血压水平。三组单肾单夹高血压大鼠分别经硝普钠、维拉帕米和出血处理后,MAP恢复正常的比例分别为30%、37%和31%。相应的向正常血压状态重调定逆转的程度分别为107±3%、40±2%和60±9%。同样,仅用维拉帕米处理的组在输注15分钟后,MAP和收缩阈压力未恢复到高血压水平。这些数据除了表明不同的血管扩张剂可因MAP类似的持续下降而对快速(15分钟)重调定(或重调定逆转)产生不同调节作用外,还提示维拉帕米对压力感受器有非特异性作用,而硝普钠似乎影响压力感受器的转导。